Profil
Brian A. Pollok was the founder of Neoantigenics, Inc. (2012) as Chief Executive Officer & Director.
Dr. Pollok was the founder of Ansata Therapeutics, Inc. (2002) as Senior Vice President-Research & Development.
Dr. Pollok is also the founder of Propagenix, Inc. Former positions include Director at University of Virginia Licensing & Ventures Group, Vice President-Discovery Biology at Aurora Biosciences Corp.
(1997-2002), Chief Scientific Officer at Invitrogen Corp., President at American Type Culture Collection (2011-2012), Principal at Wake Forest University (1987-1993), Chief Scientific Officer & Head-Global Research at Life Technologies Corp.
(2008-2011), and Senior Research Investigator at Pfizer Inc. (1993-1997).
Education includes undergraduate and graduate degrees from the University of Virginia and a doctorate from The University of Alabama (1983).
Anciens postes connus de Brian Pollok
| Sociétés | Poste | Fin |
|---|---|---|
Propagenix, Inc.
Propagenix, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops regenerative medicine | Fondateur | 01/01/2024 |
American Type Culture Collection
American Type Culture Collection BiotechnologyHealth Technology Provides biological products | President | 01/07/2012 |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Directeur Technique/Scientifique/R&D | 01/04/2011 |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | 01/07/2002 |
| PFIZER INC. | Corporate Officer/Principal | 31/12/1997 |
Formation de Brian Pollok
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Invitrogen Corp.
Invitrogen Corp. Electronic Equipment/InstrumentsElectronic Technology Develops, manufactures and sells life science research kits and provides research services | Electronic Technology |
American Type Culture Collection
American Type Culture Collection BiotechnologyHealth Technology Provides biological products | Health Technology |
Neoantigenics, Inc.
Neoantigenics, Inc. Medical SpecialtiesHealth Technology Developes therapeutic plus diagnostic products | Health Technology |
Propagenix, Inc.
Propagenix, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops regenerative medicine | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wake Forest University
Wake Forest University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Alabama
The University of Alabama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ansata Therapeutics, Inc.
Ansata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
University of Virginia Licensing & Ventures Group
University of Virginia Licensing & Ventures Group Investment ManagersFinance UVA LVG invests in companies located in the United States. The firm focuses on companies operating in the fields of technology, health and educational sectors. It provides financing for seed and early stage capital requirements. | Finance |
















